Physician Practice Affiliation Drives Site of Care Cost Differentials: An Opportunity to Reduce Healthcare Expenditures [0.03%]
医师执业关系驱动医疗场所成本差异：降低医疗支出的机会
Deepak A Kapoor,Mark Camel,David Eagle et al.
Deepak A Kapoor et al.
The continued migration of physicians from independent practice to affiliation with larger entities has garnered significant scrutiny. These affiliation models include hospitals and health systems, payers and corporate entities, and managem...
Development of a Work-Related Quality of Life Questionnaire for Medical Doctors (WQMD-9) in Japan: Questionnaire Design and Quantitative Survey [0.03%]
日本医生工作生活质量问卷（WQMD-9）的开发：问卷设计与定量调查研究
Miyuki Ezura,Katsuhiko Sawada,Yusuke Takushima et al.
Miyuki Ezura et al.
Background: With the ongoing development of game-changing technologies, assessing healthcare provider burden is desirable. This requires developing and evaluating subjective outcome measures, but there is no single scale that measures this ...
Innovative Payment Mechanisms for High-Cost Medical Devices in Latin America: Experience in Designing Outcome Protection Programs in the Region [0.03%]
拉美地区高科技医疗设备的创新支付机制：设计结果保护计划的经验
Daniela Paredes-Fernández,Juan Valencia-Zapata
Daniela Paredes-Fernández
Introduction and Objectives: Risk-sharing agreements (RSAs) have emerged as a key strategy for financing high-cost medical technologies while ensuring financial sustainability. These payment mechanisms mitigate clinical and financial uncert...
The PICO Puzzle: Can Public Data Predict EU HTA Expectations for All EU Countries? [0.03%]
PICO难题：公共数据能否预测所有欧盟国家的HTA期望？
Karolin Eberle,Lisa-Maria Hagemann,Maria Katharina Schweitzer et al.
Karolin Eberle et al.
With the European Union (EU) Health Technology Assessment (HTA) regulation, Joint Clinical Assessments (JCA) are now required for oncological and advanced therapy medicinal products. The JCA assessment scope is determined through the PICO f...
EU-HTA Guidance for Clinical Validity: Misconceptions and Flawed Processes [0.03%]
欧盟HTA关于临床有效性指南的问题：误区及缺陷过程分析
Mondher Toumi,Bruno Falissard,Asma Jouini et al.
Mondher Toumi et al.
An Estimation of the Economic and Environmental Impact of Inhaler Devices Switch for Non-Clinical Reasons in COPD and Asthma: The Case for Spain [0.03%]
从非临床因素考虑慢性阻塞性肺病和哮喘吸入器更换的经济与环境影响估算：以西班牙为例
Oriol Solà-Morales,Joan B Soriano,Míriam Solozabal-Coll et al.
Oriol Solà-Morales et al.
In respiratory patients, limited adherence to and misuse of devices hinder the effectiveness of inhalation therapy. Switching inhalers for non-clinical reasons poses a risk of deterioration of respiratory disease and/or promotes poor adhere...
Enhancing Patient Engagement in HTA: Using Consensus Research to Overcome PICO Scoping Challenges Under the EU HTAR [0.03%]
改进卫生技术评估中的患者参与：使用共识研究克服欧盟HTA法规下PICO范围界定挑战
Emanuele Arcà,Adele Barlassina,Adaeze Eze et al.
Emanuele Arcà et al.
The evolving landscape of Health Technology Assessment (HTA) in Europe, shaped by the implementation of the new EU HTA Regulation (HTAR), places an emphasis on engaging all stakeholders, including patients, in collaborative evidence generat...
Price Analysis of Systemic Therapies and Transarterial Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma [0.03%]
不可切除肝细胞癌系统性治疗和经动脉放射栓塞的费用分析
Abimbola O Williams,Nicholas Anderson,Young-Gwan Gwon et al.
Abimbola O Williams et al.
Systemic therapy (ST) and transarterial radioembolization (TARE) are widely used treatments for advanced-stage hepatocellular carcinoma (HCC). This study quantified the significant variability in treatment costs for unresectable HCC from pa...
Health and Social Care Integration: Insights from International Implementation Cases [0.03%]
医疗卫生整合：国际实施案例的启示
Ricardo Correia de Matos,Generosa do Nascimento,Adalberto Campos Fernandes et al.
Ricardo Correia de Matos et al.
The integration of health and social care is increasingly recognized as essential to address population ageing, the rise in chronic diseases, and persistent health inequities. Across Europe, diverse models have been developed to improve ser...
Exploring Trust in Health Insurers: Insights from Enrollees' Perceptions and Experiences [0.03%]
探究健康保险公司的信任度：来自参保者视角的启示
Frank J P van der Hulst,Sanne Huijgen,Anne E M Brabers et al.
Frank J P van der Hulst et al.
Managed competition is a key driver in healthcare systems in countries like Germany, Switzerland, and The Netherlands. Trust in health insurers is vital but currently low in The Netherlands. This may be due to perceptions regarding profit m...